Connect with us

Hi, what are you looking for?

Brilliant AchievementBrilliant Achievement

Editor's Pick

No, It’s Not Price Controls When Government Reduces the Prices It Pays for Medicines

Michael F. Cannon

medicaid, subsidies

UPDATE: The executive order President Trump signed today does in fact attempt to impose price controls on private purchases of prescription drugs. See this blog post for specifics. The substance of this blog post remains true. 


Government should not purchase medicines for civilians. Period. The US Medicare and Medicaid programs illustrate why. Medicare pays significantly higher prices for medicines than other government programs. Medicaid likewise overpays for prescription drugs and has spillover effects that increase drug prices for private purchasers. These programs pay excessive prices partly because Congress largely let the pharmaceutical industry write each program’s drug-pricing rules.

Government should get out of the business of purchasing or subsidizing medicines for civilians. In other words, the price that Medicare and Medicaid should be paying for drugs is $0.00. To the extent that Trump’s executive order moves the prices Medicare pays for medicines closer to the ideal price of $0.00, it is a step in the right direction.

It is not a “price control” when the government reduces the prices Medicare pays for drugs. Price controls are coercive restraints government places on private actors. If Medicare pays less for drugs, by contrast, private actors remain free to buy and sell at whatever prices make them happy.

If Congress fears that lower Medicare prices would lead to insufficient pharmaceutical research, development, and innovation, the way to correct that market failure is to adjust the patent system. Medicare is not a drug-innovation program. Moreover, the patent system is constitutional. Medicare is not.

Join The Exclusive Subscription Today And Get Premium Articles For Free
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

You May Also Like

Tech News

Image: Ford Ford announced today that it would be working with bike company N plus to introduce two new e-bikes inspired by the automaker’s...

Tech News

Image: Ford Ford announced today that it would be working with bike company N plus to introduce two new e-bikes inspired by the automaker’s...

Editor's Pick

Thomas A. Berry and Charles Brandt President Donald Trump has proclaimed himself a “drainer of the swamp” and enemy of the “deep state.” But...

Editor's Pick

After weeks of uncertainty, the stock market finally gave us something to smile about. The major indexes just wrapped up four straight days of...